Suppr超能文献

肿瘤起始的代谢决定因素。

Metabolic determinants of tumour initiation.

机构信息

Cell Biology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

出版信息

Nat Rev Endocrinol. 2023 Mar;19(3):134-150. doi: 10.1038/s41574-022-00773-5. Epub 2022 Nov 29.

Abstract

Tumours exhibit notable metabolic alterations compared with their corresponding normal tissue counterparts. These metabolic alterations can support anabolic growth, enable survival in hostile environments and regulate gene expression programmes that promote malignant progression. Whether these metabolic changes are selected for during malignant transformation or can themselves be drivers of tumour initiation is unclear. However, intriguingly, many of the major bottlenecks for tumour initiation - control of cell fate, survival and proliferation - are all amenable to metabolic regulation. In this article, we review evidence demonstrating a critical role for metabolic pathways in processes that support the earliest stages of tumour development. We discuss how cell-intrinsic factors, such as the cell of origin or transforming oncogene, and cell-extrinsic factors, such as local nutrient availability, promote or restrain tumour initiation. Deeper insight into how metabolic pathways control tumour initiation will improve our ability to design metabolic interventions to limit tumour incidence.

摘要

与相应的正常组织相比,肿瘤表现出明显的代谢改变。这些代谢改变可以支持合成代谢生长,使肿瘤在恶劣的环境中存活,并调节促进恶性进展的基因表达程序。这些代谢变化是在恶性转化过程中选择的,还是本身可以成为肿瘤起始的驱动因素尚不清楚。然而,有趣的是,肿瘤起始的许多主要瓶颈——细胞命运、存活和增殖的控制——都可以通过代谢调节来实现。在本文中,我们回顾了证明代谢途径在支持肿瘤发展早期阶段的过程中起着关键作用的证据。我们讨论了细胞内因素,如起源细胞或转化致癌基因,以及细胞外因素,如局部营养物质的可用性,如何促进或抑制肿瘤起始。更深入地了解代谢途径如何控制肿瘤起始将提高我们设计代谢干预措施来限制肿瘤发生率的能力。

相似文献

1
Metabolic determinants of tumour initiation.
Nat Rev Endocrinol. 2023 Mar;19(3):134-150. doi: 10.1038/s41574-022-00773-5. Epub 2022 Nov 29.
2
Cancer metabolism: looking forward.
Nat Rev Cancer. 2021 Oct;21(10):669-680. doi: 10.1038/s41568-021-00378-6. Epub 2021 Jul 16.
3
Metabolic Codependencies in the Tumor Microenvironment.
Cancer Discov. 2021 May;11(5):1067-1081. doi: 10.1158/2159-8290.CD-20-1211. Epub 2021 Jan 27.
4
Extracellular serine controls epidermal stem cell fate and tumour initiation.
Nat Cell Biol. 2020 Jul;22(7):779-790. doi: 10.1038/s41556-020-0525-9. Epub 2020 May 25.
5
Metabolic pathways promoting cancer cell survival and growth.
Nat Cell Biol. 2015 Apr;17(4):351-9. doi: 10.1038/ncb3124. Epub 2015 Mar 16.
6
SOX2 controls tumour initiation and cancer stem-cell functions in squamous-cell carcinoma.
Nature. 2014 Jul 10;511(7508):246-50. doi: 10.1038/nature13305. Epub 2014 Jun 8.
7
Understanding the Intersections between Metabolism and Cancer Biology.
Cell. 2017 Feb 9;168(4):657-669. doi: 10.1016/j.cell.2016.12.039.
8
Metabolic Dependencies in RAS-Driven Cancers.
Clin Cancer Res. 2015 Apr 15;21(8):1828-34. doi: 10.1158/1078-0432.CCR-14-2425.
10
Solid stress, competition for space and cancer: The opposing roles of mechanical cell competition in tumour initiation and growth.
Semin Cancer Biol. 2020 Jun;63:69-80. doi: 10.1016/j.semcancer.2019.05.004. Epub 2019 May 8.

引用本文的文献

1
Dissecting inflammation in the immunemetabolomic era.
Cell Mol Life Sci. 2025 Apr 28;82(1):182. doi: 10.1007/s00018-025-05715-8.
4
Nanotechnology-based tumor metabolic reprogramming: Insights into nutrient-delivery and metabolism reactivation therapy.
Acta Pharm Sin B. 2024 Oct;14(10):4619-4621. doi: 10.1016/j.apsb.2024.07.015. Epub 2024 Jul 20.
5
Effect of neutrophils on tumor immunity and immunotherapy resistance with underlying mechanisms.
Cancer Commun (Lond). 2025 Jan;45(1):15-42. doi: 10.1002/cac2.12613. Epub 2024 Nov 1.
6
Co-targeting metabolism and epigenetics in MDS with telaglenastat and azacytidine.
Nat Cancer. 2024 Oct;5(10):1455-1456. doi: 10.1038/s43018-024-00812-2.
8
The mevalonate pathway contributes to breast primary tumorigenesis and lung metastasis.
Mol Oncol. 2025 Jan;19(1):56-80. doi: 10.1002/1878-0261.13716. Epub 2024 Aug 9.
9
Review: Cancer and neurodevelopmental disorders: multi-scale reasoning and computational guide.
Front Cell Dev Biol. 2024 Jul 2;12:1376639. doi: 10.3389/fcell.2024.1376639. eCollection 2024.
10
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets.
Signal Transduct Target Ther. 2024 Jun 19;9(1):149. doi: 10.1038/s41392-024-01848-7.

本文引用的文献

2
β-Hydroxybutyrate suppresses colorectal cancer.
Nature. 2022 May;605(7908):160-165. doi: 10.1038/s41586-022-04649-6. Epub 2022 Apr 27.
3
Targeting ferroptosis as a vulnerability in cancer.
Nat Rev Cancer. 2022 Jul;22(7):381-396. doi: 10.1038/s41568-022-00459-0. Epub 2022 Mar 25.
5
The hallmarks of cancer metabolism: Still emerging.
Cell Metab. 2022 Mar 1;34(3):355-377. doi: 10.1016/j.cmet.2022.01.007. Epub 2022 Feb 4.
6
The role of ROS in tumour development and progression.
Nat Rev Cancer. 2022 May;22(5):280-297. doi: 10.1038/s41568-021-00435-0. Epub 2022 Jan 31.
7
Reuterin in the healthy gut microbiome suppresses colorectal cancer growth through altering redox balance.
Cancer Cell. 2022 Feb 14;40(2):185-200.e6. doi: 10.1016/j.ccell.2021.12.001. Epub 2021 Dec 23.
8
"Sweet death": Fructose as a metabolic toxin that targets the gut-liver axis.
Cell Metab. 2021 Dec 7;33(12):2316-2328. doi: 10.1016/j.cmet.2021.09.004. Epub 2021 Oct 6.
9
Targeting integrated epigenetic and metabolic pathways in lethal childhood PFA ependymomas.
Sci Transl Med. 2021 Oct 6;13(614):eabc0497. doi: 10.1126/scitranslmed.abc0497.
10
Dietary suppression of MHC class II expression in intestinal epithelial cells enhances intestinal tumorigenesis.
Cell Stem Cell. 2021 Nov 4;28(11):1922-1935.e5. doi: 10.1016/j.stem.2021.08.007. Epub 2021 Sep 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验